Resorts World Sentosa operator may bid for casino licence to tap influx of foreign tourists.
KUALA LUMPUR: Genting Singapore, the operator of Resorts World Sentosa, may likely be the front-runner to secure a license for an integrated resort (IR) and casino in Thailand if the Thai government decides to deregulate the industry, according to analysts.
Correct, there are plenty of opportunities in Bursa in coming months.
Bursa was languishing low in past 3 years as there was lack of interests from foreign funds and local funds were not buying much too (as EPF faced billions of ringgit of withdrawal in 2022-2023).
Now things are looking much better as can be seen in the strong foreign funds buying since the 1st week of 2024. We should reckon the fact that for big stocks to move, we need foreign funds participation in Bursa.
Hence, I focus on those big caps that are favoured by foreign funds such as YTL (UBS just added another 5.6m shares last week), YTL Power (foreign funds bought some 45m shares last week) and Genting (foreign funds holding is still very low, leaving rooms for higher).
Genting made 13.52 sen a share during the July to September quarter. If it could maintain or even improve on its earnings in its subsequent quarters, its full year eps this year should be not less than 55 sen. Assuming a conservative PE of 12, it should be worth RM6.60 a share.
All,I know from my U.K. contact is that the approval process is well advanced …subject to more data from extended trial….the data over 24 month period is being analysed ..and to be presented….that’s what I heard what it actually means no Idea! I feel we will know definitely this year.
TauRx Pharmaceutical Ltd (“TauRx”) is currently pursuing regulatory interactions and submissions for HMTM. The UK Medicines & Healthcare products Regulatory Agency (MHRA) has granted TauRx an Innovation Passport in May 2022 (prior to the release of LUCIDITY data). The Innovation Passport is the first stage of the Innovative Licensing and Access Pathway, which is intended to accelerate development and approval times, facilitating access to new products and indications. As for the USA regulatory process, the U.S. Food and Drug Administration (FDA), TauRx intends to continue its engagement with the FDA. In parallel, TauRx continues to have strong key opinion leaders engagement as it works towards its commercialisation strategy
With these approvals, the Management of TauRx will engage discussion with potential investors and strategic investors with the hope of monetization opportunity.
@clarachan I think some analyst expect genting to double if taurx is successful. But I largely think it depends on which country approves and how much they can sell the drug for
GENTING also I the midst to monetize it's 2.6 trillion cubic feet per day natural gas which expect to achieve first drop of gas in Kasuri Block by Q2 of 2026, allows the supply of 230 mmcfd of natural gas to the FLNG facility for 18 years, as well as another supply of 101 mmcfd of natural gas to an Ammonia and Urea plant to be built in West Papua, Indonesia for 17 years.
Posted by Kikilala3188 > 4 hours ago | Report Abuse Taurx when will it be announcing? Especially U.K. FDA approval ---------------
UK MHRA's final decision on CA is unlikely to be within 2024. We still have to file in more submissions which will take abt 5 to 6 months to complete it, followed by another 6 to 9 months for the regulator's final decision.
FDA delayed our Type C meeting request (supposed to be end Jan, before Taurx AGM on 6 Feb @6pm). We are not even sure if FDA will agree to consider HMTM using the Accelerated Approval pathway. If yes, I think FDA's final decision for AA will probably be at least 1.5yrs away.
Slow so slow…..compare Genting to CIMB which is motoring along…was in deep trouble when covid hit with significant write offs….the difference in performance is mainly because Cimb does nit have party related transactions and single major owner like Genting has who dumps shares and buys them back or entertains party related transactions…..from time to time ….whilst business itself is recovering the share dealing is an issue. Most CEO don't actively trade in their own shares and get listed entities to bail out their private investments. No matter how the business is doing and recovering this is the issue which is impacting the share price. To be honest the regulators need to look at these transactions as it has negative impact on shareholders which they should be protecting….! Sorry for repeating the point …I am confident the business results will improve …significantly.
Genting belongs to Consumer Index, it has a strong resistance at 564+, Genting has a strong resistance at 4.90-5.00, every times genting was sold when reaching both resistance. Wait for a good news which can precipitating a successful breakout of both resistances
Newly open USD 4.3 billion Resorts World Las Vegas. These wholly own casino resort has emerge become the third largest earning contributor to Genting in less than 2 year operation.
If momentum persit, It could surpass local Genting Malaysia once reach optimum operation. Las Vagas now have surpass 1 million memberships after just 2 year operation
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
dragon328
2,576 posts
Posted by dragon328 > 2024-01-26 14:15 | Report Abuse
haha I am still in YTL YTLPower Genting and now PBA